Form D/A — Mitotherapeutix, LLC
0001657701-25-000002 · filed May 22, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,967,643
- Reported amount sold
- $2,967,643
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mitotherapeutix, LLC
- CIK
- 1657701
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4 Research Drive
Woodbridge, CT 06525 - Phone
- 203-498-4411
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert Hennessey · Executive OfficerWoodbridge, CT Find on LinkedIn ↗
-
Robert Hemley · Executive OfficerWoodbridge, CT Find on LinkedIn ↗
-
John V. Talley · Executive OfficerWoodbridge, CT Find on LinkedIn ↗
-
Fenel Eloi · DirectorWoodbridge, CT Find on LinkedIn ↗
-
Daniel Wagner · DirectorWoodbridge, CT Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗